Regeneron Pharmaceuticals has signed a new licensing agreement with Hansoh Pharmaceuticals Group to develop and sell its weight loss therapy outside of China.

New UK research reveals that combining weight loss injections with coaching and regular tracking can lead to 53% more ...

"We recommend that any patients experiencing side effects while taking GLP-1 receptor agonists including Wegovy® (semaglutide ...

How weight loss demand is draining Europe’s diabetes drug supply, as countries adopt varying speeds of approach to medicinal ...

A popular weight-loss drug may be changing how doctors treat obesity—but scientists are just starting to uncover exactly how ...

Primary care physicians aren’t quick to diagnose lymphedema in patients with obesity, a situation that needs to change, ...

Regeneron Pharmaceuticals has signed a new licensing agreement with Hansoh Pharmaceuticals Group to develop and sell its weight loss therapy ... which is known as tirzepatide and marketed as ...

Eli Lilly and Company today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro), retatrutide, eloralintide and bimagrumab will be presented at ...

Dozens of Ozempic, Mounjaro and Wegovy users are reporting drug-induced hepatitis, prompting medical experts to call for ...

The US drugmaker has stolen a march on Novo Nordisk by bringing a viable oral weight-loss medicine, orforglipron, into successful phase 3 clinical trials. An oral version is the holy grail for drugs ...